EyePoint Pharmaceuticals, Inc. 8-K

Accession 0000950170-23-032444

Filing information

CIK: 0001314102
Report date: 2023-07-11
Filing date: 2023-07-11
Form: 8-K
Primary document: eypt-20230711.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.